Complement Factor H Polymorphism and Age-Related Macular Degeneration
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is a common, late-onset, and complex trait with multiple risk factors. Concentrating on a region harboring a locus for AMD on 1q25-31, the ARMD1 locus, we tested single-nucleotide polymorphisms for association with AMD in two independent case-control populations. Significant association ( P = 4.95 × 10 -10 ) was identified within the regulation of complement activation locus and was centered over a tyrosine-402 → histidine-402 protein polymorphism in the gene encoding complement factor H. Possession of at least one histidine at amino acid position 402 increased the risk of AMD 2.7-fold and may account for 50% of the attributable risk of AMD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A major AMD-associated SNP is the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Edwards et al., 2005
In the citing paper
“Complement activation playing a major role in AMD pathogenesis is yet another source of inflammation [107-110].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [108]
In the citing paper
“Polymorphisms in human complement regulatory factor H (CFH) predispose individuals to AMD [35, 46, 59]”
From Fecal microbiota transfer between young and aged mice reverses hallmarks of the aging gut, eye, and brain (2022) · cites this paper as [35]
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [4]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Score Tests for Association between Traits and Haplotypes when Linkage Phase Is Ambiguous
Schaid, D. J., Rowland, C. M., Tines, D. E., Jacobson, R. M., & Poland, G. A. (2002) · The American Journal of Human Genetics · doi:10.1086/338688 · Cited by 1,783
The Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, B. E. K., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,135
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Seddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.6.785 · Cited by 398
Keenan, T. D., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 377
Research works printed but not linked: 1
- M. H. Wener, P. R. Daum, G. M. McQuillan, J. Rheumatol.27, 2351 (2000).
Cited by
Items 401–500 of 1,021
A forest-based approach to identifying gene and gene–gene interactions
Chen, X. '., Liu, C., Zhang, M., & Zhang, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709868104 · Cited by 114
The success of the genome-wide association approach: a brief story of a long struggle
Seng, K. C., & Seng, C. K. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.12 · Cited by 123
Genetic factors define CPO and CLO subtypes of nonsyndromicorofacial cleft
Huang, L., Jia, Z., Shi, Y., Du, Q., Shi, J., Wang, Z., Mou, Y., Wang, Q., Zhang, B., Wang, Q., et al. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008357 · Cited by 118
Environmental tobacco smoke exposure and eye disease
Lois, N., Abdelkader, E., Reglitz, K., Garden, C., & Ayres, J. G. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2008.141168 · Cited by 118
Wiley, L. A., Burnight, E. R., Songstad, A. E., Drack, A. V., Mullins, R. F., Stone, E. M., & Tucker, B. A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.10.002 · Cited by 124
Basal Laminar Drusen Caused by Compound Heterozygous Variants in the CFH Gene
Boon, C. J. F., Klevering, B. J., Hoyng, C. B., Zonneveld-Vrieling, M. N., Nabuurs, S. B., Blokland, E. A. W., Cremers, F. P. M., & den Hollander, A. I. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.11.007 · Cited by 116
Chen, Y., Hu, Y., Lu, K., Flannery, J. G., & Ma, J.-X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611289200 · Cited by 92
Genome-wide association study of blast resistance in indica rice
Wang, C., Yang, Y., Yuan, X., Xu, Q. J., Feng, Y., Yu, H., Wang, Y., & Wei, X. (2014) · BMC Plant Biology · doi:10.1186/s12870-014-0311-6 · Cited by 109
“In 2005, GWAS was first applied to a human disease, age-related macular degeneration [14].”
MethodThe challenges and promise of complement therapeutics for ocular diseases
Park, D. H., Connor, K. M., & Lambris, J. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01007 · Cited by 108
Wang, J., Ohno‐Matsui, K., Yoshida, T., Shimada, N., Ichinose, S., Sato, T., Mochizuki, M., & Morita, I. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21742 · Cited by 105
“…genes coding for complement factor H and factor B, both of which are key components of the alternative pathway, have been shown to be predictors for the development of AMD (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Gold et al., 2006; Maller et al., 2006).”
BackgroundLee, K. Y., Vithana, E. N., Mathur, R., Yong, V. H. K., Yeo, I. Y. S., Thalamuthu, A., Lee, M., Koh, A. H. C., Lim, M. C. C., How, A. C. S., et al. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0860 · Cited by 109
Review of Genetics in Age Related Macular Degeneration
Montezuma, S. R., Sobrin, L., & Seddon, J. M. (2007) · Seminars in Ophthalmology · doi:10.1080/08820530701745140 · Cited by 106
Yamada, Y., Ishibashi, K., Ishibashi, K., Bhutto, I. A., Tian, J. Y., Lutty, G. A., & Handa, J. T. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.005 · Cited by 116
“…stress and induction of inflammation, a potential mechanism of AMD that has gained increased interest due to the recent strong association of polymorphisms in complement factor H with AMD (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Zareparsi et al., 2005).”
BackgroundMouse models of age-related macular degeneration
Elizabeth Rakoczy, P., Yu, M. J. T., Nusinowitz, S., Chang, B., & Heckenlively, J. R. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.012 · Cited by 107
Smailhodzic, D., Muether, P. S., Chen, J. L., Kwestro, A., Zhang, A. Y., Omar, A., van de Ven, J. P. H., KEUNEN, J. E. E., Kirchhof, B., Hoyng, C. B., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.05.040 · Cited by 123
The eye as a complement dysregulation hotspot
Clark, S. J., & Bishop, P. N. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-017-0649-6 · Cited by 103
Lipids, Lipoproteins, and Age-Related Macular Degeneration
Ebrahimi, K. B., & Handa, J. T. (2011) · Journal of Lipids · doi:10.1155/2011/802059 · Cited by 105
Implementation and utilization of genetic testing in personalized medicine
Scott, S., Abul-Husn, N., Owusu Obeng, A., Sanderson, S., & Gottesman, O. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s48887 · Cited by 106
Transgenic Mice Expressing Variants of Complement Factor H Develop AMD-like Retinal Findings
Ufret-Vincenty, R. L., Aredo, B., Liu, X., McMahon, A., Chen, P. W., Sun, H., Niederkorn, J. Y., & Kedzierski, W. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4457 · Cited by 104
Regulation of the Complement System by Pentraxins
Haapasalo, K., & Meri, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01750 · Cited by 115
Scott, W. K., Schmidt, S., Hauser, M. A., Gallins, P. J., Schnetz‐Boutaud, N. C., Spencer, K. L., Gilbert, J. R., Agarwal, A., Postel, E. A., Haines, J. L., et al. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.08.054 · Cited by 114
Crabb, J. W. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017194 · Cited by 100
“Whereas CFH has been reported to bind malondialdehyde and POVPC, oxidative modifications such as carboxymethyllysine and carboxyethylpyrrole trigger immune responses through other pattern recognition receptors such as RAGE, TLR2, and TLR9.”
BackgroundInfluentialApolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD)
Baird, P. N., Richardson, A. J., Robman, L. D., Dimitrov, P. N., Tikellis, G., McCarty, C. A., & Guymer, R. H. (2006) · Human Mutation · doi:10.1002/humu.20288 · Cited by 105
“Along with the recently reported complement factor H gene [Klein et al., 2005; Edwards et al., 2005; Haines et al., 2005; Hageman et al., 2005], the apolipoprotein gene (APOE) (MIM] 107741) also appears as a genetic risk factor that has been associated with AMD in several studies involving…”
BackgroundFunctional modules, mutational load and human genetic disease
Zaghloul, N. A., & Katsanis, N. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.01.006 · Cited by 104
Clarkson, S. G., & Wood, R. D. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.07.001 · Cited by 105
Scholl, H. P. N., Fleckenstein, M., Fritsche, L. G., Schmitz-Valckenberg, S., Göbel, A., Adrion, C., Herold, C., Keilhauer, C. N., Mackensen, F., Mößner, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007418 · Cited by 104
Zeiss, C. J. (2010) · Veterinary Pathology · doi:10.1177/0300985809359598 · Cited by 102
“The first complement associated gene polymorphism to be identified in AMD populations was the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH).(28,44,47,62) Individuals homozygous for the risk-conferring 402H CFH variant have a five- to sevenfold greater risk of develop…”
BackgroundMethodVogt, S. D., Curcio, C. A., Wang, L., Li, C.-M., McGwin, G., Medeiros, N. E., Philp, N. J., Kimble, J. A., & Read, R. W. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.06.002 · Cited by 104
“…Wang et al., 2010b) and alterations in complement factors, both pro-inflammatory(Jakobsdottir et al., 2008; McKay et al., 2009) and regulatory,(Edwards et al., 2005; Hageman, 2005; Haines et al., 2005; Jakobsdottir et al., 2008; Klein et al., 2005; Zareparsi et al., 2005) associated with…”
BackgroundInfluentialDeAngelis, M. M., Ji, F., Adams, S., Morrison, M. A., Harring, A. J., Sweeney, M. O., Capone, A., Miller, J. W., Dryja, T. P., Ott, J., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.032 · Cited by 104
Ao, J., Wood, J. P. M., Chidlow, G., Gillies, M. C., & Casson, R. J. (2018) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13121 · Cited by 112
Landowski, M., Kelly, U., Klingeborn, M., Groelle, M., Ding, J.-D., Grigsby, D., & Bowes Rickman, C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814014116 · Cited by 103
The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration
Brown, E. E., Ball, J. D., Chen, Z., Khurshid, G. S., Prosperi, M., & Ash, J. D. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26422 · Cited by 107
Cipriani, V., Lorés-Motta, L., He, F., Fathalla, D., Tilakaratna, V., McHarg, S., Bayatti, N., Acar, İ. E., Hoyng, C. B., Fauser, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14499-3 · Cited by 101
Macular dystrophies mimicking age-related macular degeneration
Saksens, N. T. M., Fleckenstein, M., Schmitz-Valckenberg, S., Holz, F. G., den Hollander, A. I., KEUNEN, J. E. E., Boon, C. J. F., & Hoyng, C. B. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.11.001 · Cited by 112
“On chromosome 1, a strong association was identifiedwith variants in the complement factor H (CFH) gene, suggesting an involvement of the complement cascade in AMD pathogenesis (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
BackgroundThe Pathogenic Role of the Canonical Wnt Pathway in Age-Related Macular Degeneration
Zhou, T., Hu, Y., Chen, Y., Zhou, K., Zhang, B., Gao, G., & Ma, J. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4278 · Cited by 108
Rutar, M., Natoli, R., Kozulin, P., Valter, K., Gatenby, P., & Provis, J. M. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-7119 · Cited by 100
The Role of the Immune Response in Age-Related Macular Degeneration
Whitcup, S. M., Sodhi, A., Atkinson, J. P., Holers, V. M., Sinha, D., Rohrer, B., & Dick, A. D. (2013) · International Journal of Inflammation · doi:10.1155/2013/348092 · Cited by 98
Immunosuppressive Properties of the Pigmented Epithelial Cells and the Subretinal Space
Zamiri, P., Sugita, S., & Streilein, J. W. (2007) · Chemical Immunology and Allergy · doi:10.1159/000099259 · Cited by 100
RPE cell senescence: A key contributor to age-related macular degeneration
Kozlowski, M. R. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.01.018 · Cited by 110
Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration
Spencer, K. L., Hauser, M. A., Olson, L. M., Schmidt, S., Scott, W. K., Gallins, P., Agarwal, A., Postel, E. A., Pericak-Vance, M. A., & Haines, J. L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm369 · Cited by 102
Zipfel, P. F., Lauer, N., & Skerka, C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_2 · Cited by 115
“Initiated by the Human Genome Project in 2005, four independent genome-wide linkage studies identified two major chromosomal loci that confer major risk for this retinal disease and that account for approximately 50% of cases (Edwards et al. 2005; Haines et al. 2005; Klein et al. 2005; Rivera et al. 2005).”
BackgroundOn the origin of proteins in human drusen: The meet, greet and stick hypothesis
Bergen, A. A., Arya, S., Koster, C., Pilgrim, M. G., Wiatrek-Moumoulidis, D., van der Spek, P. J., Hauck, S. M., Boon, C. J. F., Emri, E., Stewart, A. J., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.12.003 · Cited by 101
Schadt, E. E., & Lum, P. Y. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600026-jlr200 · Cited by 101
Ding, J., Lin, J. C., Mace, B. E., Herrmann, R., Sullivan, P. M., & Rickman, C. B. (2007) · Vision Research · doi:10.1016/j.visres.2007.07.025 · Cited by 109
Lin, M. K., Yang, J., Hsu, C. W., Gore, A. M., Bassuk, A. G., Brown, L. M., Colligan, R. M., Sengillo, J. D., Mahajan, V. B., & Tsang, S. H. (2018) · Aging Cell · doi:10.1111/acel.12710 · Cited by 107
Hollyfield, J. G., Perez, V. L., & Salomon, R. G. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8110-z · Cited by 97
Saccà, S. C., Roszkowska, A. M., & Izzotti, A. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.01.001 · Cited by 107
Chen, M., Muckersie, E., Robertson, M., Forrester, J. V., & Xu, H. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.09.005 · Cited by 99
The proteome of central and peripheral retina with progression of age-related macular degeneration
Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1395 · Cited by 99
C2 and CFB Genes in Age-Related Maculopathy and Joint Action with CFH and LOC387715 Genes
Jakobsdottir, J., Conley, Y. P., Weeks, D. E., Ferrell, R. E., & Gorin, M. B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002199 · Cited by 97
“A genome-wide association scan [6] and two targeted searches [7,8] identified variants in the complement factor H (CFH, Entrez GeneID 3075) gene on chromosome 1q32 and two targeted searches [9,10] identified variants in the poorly characterized LOC387715 (also known as ARMS2, GeneID 387715) gene, as well as in the clo…”
BackgroundAge-Dependent Retinal Iron Accumulation and Degeneration in Hepcidin Knockout Mice
Hadziahmetovic, M., Song, Y., Ponnuru, P., Iacovelli, J., Hunter, A., Haddad, N., Beard, J., Connor, J. R., Vaulont, S., & Dunaief, J. L. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6113 · Cited by 98
Bharti, K., den Hollander, A. I., Lakkaraju, A., Sinha, D., Williams, D. S., Finnemann, S. C., Rickman, C. B., Malek, G., & D'Amore, P. A. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109170 · Cited by 104
Recent Advances in Age-Related Macular Degeneration Therapies
Fabre, M., Mateo, L., Lamaa, D., Baillif, S., Pagès, G., Demange, L., Ronco, C., & Benhida, R. (2022) · Molecules · doi:10.3390/molecules27165089 · Cited by 111
Molecular genetics of AMD and current animal models
Edwards, A. O., & Malek, G. (2007) · Angiogenesis · doi:10.1007/s10456-007-9064-2 · Cited by 107
Self-citationWet age-related macular degeneration
KULKARNI, A., & Kuppermann, B. D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.003 · Cited by 116
A typology of photoreceptor gene expression patterns in the mouse
Corbo, J. C., Myers, C. A., Lawrence, K. A., Jadhav, A. P., & Cepko, C. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705465104 · Cited by 97
The molecular genetic basis of age-related macular degeneration: an overview
Katta, S., Kaur, I., & Chakrabarti, S. (2009) · Journal of Genetics · doi:10.1007/s12041-009-0064-4 · Cited by 121
Kenney, M. C., Chwa, M., Atilano, S. R., Pavlis, J. M., Falatoonzadeh, P., Ramirez, C., Malik, D., Hsu, T., Woo, G., Soe, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054339 · Cited by 96
Age-Related Macular Degeneration
Khandhadia, S., Cherry, J., & Lotery, A. J. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_2 · Cited by 107
The multifaceted impact of complement on atherosclerosis
Kiss, M. G., & Binder, C. J. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.03.014 · Cited by 112
Discrimination between host and pathogens by the complement system
Pangburn, M. K., Ferreira, V. P., & Cortes, C. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.023 · Cited by 94
“ARMD is strongly linked to a single amino acid variant in the seventh domain of factor H (Figure 2) [12,14,15,78].”
BackgroundLo, H., Tang, C. M., & Exley, R. M. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70132-x · Cited by 115
Campa, C., Costagliola, C., Incorvaia, C., Sheridan, C., Semeraro, F., Nadai, K. D., Sebastiani, A., & Parmeggiani, F. (2010) · Mediators of Inflammation · doi:10.1155/2010/546826 · Cited by 102
Successful design and conduct of genome-wide association studies
Amos, C. I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm161 · Cited by 98
Inflammatory Mechanisms of Age-related Macular Degeneration
Knickelbein, J. E., Chan, C.-C., Sen, H. N., Ferris, F. L., & Nussenblatt, R. B. (2015) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000073 · Cited by 97
Localization of Age-Related Macular Degeneration-Associated ARMS2 in Cytosol, Not Mitochondria
Wang, G., Spencer, K. L., Court, B. L., Olson, L. M., Scott, W. K., Haines, J. L., & Pericak‐Vance, M. A. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3240 · Cited by 103
Apolipoprotein Localization in Isolated Drusen and Retinal Apolipoprotein Gene Expression
Li, C.-M., Clark, M. E., Chimento, M. F., & Curcio, C. A. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1446 · Cited by 93
Hollyfield, J. G. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4478 · Cited by 107
Choriocapillaris changes in dry age-related macular degeneration and geographic atrophy: a review
Arya, M., Sabrosa, A. S., Duker, J. S., & Waheed, N. K. (2018) · Eye and Vision · doi:10.1186/s40662-018-0118-x · Cited by 101
A Systematic Investigation on Complement Pathway Activation in Diabetic Retinopathy
Hameed, S. S., Vishwakarma, S., Chhablani, J. K., Tyagi, M., Pappuru, R. R., Jakati, S., Chakrabarti, S., & Kaur, I. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00154 · Cited by 103
The Role of Inflammation in Retinal Neurodegeneration and Degenerative Diseases
Kaur, G., & Singh, N. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010386 · Cited by 101
“a chronic inflammatory cycle, the hallmark of the mentioned disorders [46,47].”
BackgroundBlue light–filtering intraocular lenses: Review of potential benefits and side effects
Cuthbertson, F. M., Peirson, S. N., Wulff, K., Foster, F., & Downes, S. M. (2009) · Journal of Cataract & Refractive Surgery · doi:10.1016/j.jcrs.2009.04.017 · Cited by 106
“Large longterm epidemiologic studies are needed to determine whether blue light–filtering IOLs are effective in preventing the development or progression of AMD.”
BackgroundInfluentialStudying Age-Related Macular Degeneration Using Animal Models
Fletcher, E. L., Jobling, A. I., Greferath, U., Mills, S. A., Waugh, M., Ho, T., de Iongh, R. U., Phipps, J. A., & Vessey, K. A. (2014) · Optometry and Vision Science · doi:10.1097/opx.0000000000000322 · Cited by 93
Estimation of Systemic Complement C3 Activity in Age-Related Macular Degeneration
Sivaprasad, S. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.4.515 · Cited by 94
Inflammation in Retinal Disease
Whitcup, S. M., Nussenblatt, R. B., Lightman, S., & Hollander, D. (2013) · International Journal of Inflammation · doi:10.1155/2013/724648 · Cited by 98
Zysset-Burri, D. C., Keller, I., Berger, L. E., Largiadèr, C. R., Wittwer, M., Wolf, S., & Zinkernagel, M. S. (2020) · npj Genomic Medicine · doi:10.1038/s41525-020-00141-0 · Cited by 94
Complement Component C3 and Risk of Age-Related Macular Degeneration
Despriet, D. D. G., van Duijn, C. M., Oostra, B. A., Uitterlinden, A. G., Hofman, A., Wright, A. F., ten Brink, J. B., Bakker, A., de Jong, P. T. V. M., Vingerling, J. R., et al. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.09.055 · Cited by 94
Genetics of age-related macular degeneration: current concepts, future directions
DeAngelis, M. M., Silveira, A. C., Carr, E. A., & Kim, I. K. (2011) · Seminars in Ophthalmology · doi:10.3109/08820538.2011.577129 · Cited by 94
Developments in anti-complement therapy; from disease to clinical trial
Harris, C. L., Pouw, R. B., Kavanagh, D., Sun, R., & Ricklin, D. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.008 · Cited by 91
The eye: A window to the soul of the immune system
Perez, V. L., Saeed, A. M., Tan, Y. C. R. S., Urbieta, M., & Cruz‐Guilloty, F. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.011 · Cited by 93
Looking Chloride Channels Straight in the Eye: Bestrophins, Lipofuscinosis, and Retinal Degeneration
Hartzell, C., Qu, Z., Putzier, I., Artinian, L., Chien, L.-T., & Cui, Y. (2005) · Physiology · doi:10.1152/physiol.00021.2005 · Cited by 89
“This is interesting in light of the fact that specific polymorphisms in complement factor H correlate strongly with susceptibility to AMD (17, 30, 31).”
BackgroundInfluentialUnderstanding Genetic Factors in Idiopathic Scoliosis, a Complex Disease of Childhood
Wise, C. A., Gao, X., Shoemaker, S., Gordon, D., & Herring, J. A. (2008) · Current Genomics · doi:10.2174/138920208783884874 · Cited by 109
Saunders, R. E., Goodship, T. H. J., Zipfel, P. F., & Perkins, S. J. (2006) · Human Mutation · doi:10.1002/humu.20268 · Cited by 90
“FH has been implicated with AMD of the eye retina, the leading cause of blindness in the developed world, through the observation of a Tyr402His polymorphism in SCR-7 in affected patients [Klein et al., 2005; Haines et al., 2005; Hageman et al., 2005; Edwards et al., 2005].”
BackgroundMettu, P. S., Wielgus, A. R., Ong, S. S. Y., & Cousins, S. W. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.04.006 · Cited by 102
Wang, L., Kondo, N., Cano, M., Ebrahimi, K., Yoshida, T., Barnett, B. P., Biswal, S., & Handa, J. T. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.01.015 · Cited by 89
Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions
Kim, B. J., Mastellos, D. C., Li, Y., Dunaief, J. L., & Lambris, J. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100936 · Cited by 88
Complement regulator factor H as a serum biomarker of multiple sclerosis disease state
Ingram, G., Hakobyan, S., Hirst, C. L., Harris, C. L., Pickersgill, T. P., Cossburn, M., Loveless, S., Robertson, N. P., & Morgan, B. P. (2010) · Brain · doi:10.1093/brain/awq085 · Cited by 96
“Serum factor H is the major fluid-phase regulator of the alternative pathway of complement, increasingly recognized as a critical player in many diseases (Oksjoki et al., 2003; Edwards et al., 2005; Pickering and Cook, 2008; Thambisetty et al., 2008).”
Hakobyan, S., Harris, C. L., Tortajada, A., Goicochea de Jorge, E., Garci´a-Layana, A., Ferna´ndez-Robredo, P., Rodri´guez de Co´rdoba, S., & Morgan, B. P. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1523 · Cited by 89
de Lima, L. H. S. G., Schubert, C., Ferrara, D., Merriam, J. E., Imamura, Y., Freund, K. B., Spaide, R. F., Yannuzzi, L. A., & Allikmets, R. L. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.12.018 · Cited by 93
Francis, P. J., George, S., Schultz, D. W., Rosner, B., Hamon, S., Ott, J., Weleber, R. G., Klein, M. L., & Seddon, J. M. (2007) · Human Heredity · doi:10.1159/000100046 · Cited by 91
The spectrum of phenotypes caused by variants in the CFH gene
Boon, C. J. F., van de Kar, N. C. A. J., Klevering, B. J., KEUNEN, J. E. E., Cremers, F. P. M., Klaver, C. C. W., Hoyng, C. B., Daha, M. R., & den Hollander, A. I. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.013 · Cited by 105
Targeting the complement system in systemic lupus erythematosus and other diseases
Barilla-LaBarca, M.-L., Toder, K., & Furie, R. A. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.02.014 · Cited by 97
Bora, N. S., Kaliappan, S., Jha, P., Xu, Q., Sivasankar, B., Harris, C. L., Morgan, B. P., & Bora, P. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1783 · Cited by 90
Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment
Brockmöller, J., & Tzvetkov, M. V. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0424-z · Cited by 116
Eliminating Complement Factor D Reduces Photoreceptor Susceptibility to Light-Induced Damage
Rohrer, B., Guo, Y., Kunchithapautham, K., & Gilkeson, G. S. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0282 · Cited by 90
Ko, D. C., Shukla, K. P., Fong, C. T., Wasnick, M., Brittnacher, M., Wurfel, M. M., Holden, T. D., O’Keefe, G. E., Yserloo, B. V., Akey, J. M., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.07.012 · Cited by 94
Kardys, I., Klaver, C. C. W., Despriet, D. D. G., Bergen, A. A. B., Uitterlinden, A. G., Hofman, A., Oostra, B. A., van Duijn, C. M., de Jong, P. T. V. M., & Witteman, J. C. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.076 · Cited by 97
Sequence features in regions of weak and strong linkage disequilibrium
Smith, A. V., Thomas, D. J., Munro, H. M., & Abecasis, G. R. (2005) · Genome Research · doi:10.1101/gr.4421405 · Cited by 90
Baird, P. N., Robman, L. D., Richardson, A. J., Dimitrov, P. N., Tikellis, G., McCarty, C. A., & Guymer, R. H. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn018 · Cited by 90
Complement factor H binds to denatured rather than to native pentameric C-reactive protein
Hakobyan, S., Harris, C. L., van den Berg, C. W., Fernandez-Alonso, M. C., de Jorge, E. G., de Cordoba, S. R., Rivas, G., Mangione, P., Pepys, M. B., & Morgan, B. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803648200 · Cited by 90
Metadata
- Authors
- Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A.
- Affiliations
- Boston University (US)
- Corresponding author
- Edwards, Albert O.
- Venue
- Science
- Published
- 2005-04-15
- Volume
- 308
- Issue
- 5720
- Pages
- 421-424
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3145351529
- Cited by
- 2,449
- References
- 30
- Citations by year
- 2026: 24 · 2025: 41 · 2024: 51 · 2023: 48 · 2022: 78 · 2021: 105 · 2020: 73 · 2019: 52 · 2018: 81 · 2017: 65 · 2016: 89 · 2015: 120 · 2014: 141 · 2013: 146 · 2012: 166
- FWCI
- 195.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Eye Institute (EY014467, R01EY014467)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, complement factor H, CFH Y402H polymorphism, single nucleotide polymorphisms, genetic association, disease risk
- MeSH terms
- Aged, Alleles, Chromosomes, Human, Pair 1, Complement Activation, Female, Gene Frequency, Multigene Family, Genotype, Haplotypes, Histidine, Homozygote, Humans, Macular Degeneration, Male, Middle Aged, Risk Factors, Tyrosine, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Complement Factor H, Amino Acid Substitution, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.